{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:27:43Z","timestamp":1759962463401},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.reuma.2016.06.003","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T14:04:13Z","timestamp":1470405853000},"page":"210-213","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases"],"prefix":"10.1016","volume":"13","author":[{"given":"Juan P.","family":"Vinicki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Garc\u00eda-Vicu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Arredondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan P.","family":"L\u00f3pez-Bote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas A.","family":"Garc\u00eda-Vadillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"\u00c1lvaro-Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2016.06.003_bib0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/rheumatology\/kei266","article-title":"Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis","volume":"45","author":"Park","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.reuma.2016.06.003_bib0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/rheumatology\/keh058","article-title":"Tissue production of pro-inflammatory cytokines (IL-1 beta, TNF alpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant cell arteritis","volume":"43","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reuma.2016.06.003_bib0095","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu arteritis","volume":"120","author":"Kerr","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.reuma.2016.06.003_bib0100","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/art.20300","article-title":"Antitumornecrosis factor therapy in patients with difficult to treat Takayasu arteritis","volume":"50","author":"Hoffman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2016.06.003_bib0105","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/ard.2008.093260","article-title":"Anti-tumournecrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up","volume":"67","author":"Molloy","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2016.06.003_bib0110","first-page":"1079","article-title":"Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term follow-up","volume":"64","author":"Schmidt","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.reuma.2016.06.003_bib0115","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/ker380","article-title":"Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study","volume":"51","author":"Mekinian","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reuma.2016.06.003_bib0120","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.autrev.2013.06.019","article-title":"Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review","volume":"12","author":"Abisror","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reuma.2016.06.003_bib0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/RHU.0000000000000098","article-title":"Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis","volume":"20","author":"Ca\u00f1as","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.reuma.2016.06.003_bib0130","first-page":"79","article-title":"Tocilizumab in refractory aortitis: study on 16, patients and literature review","volume":"32","author":"Loricera","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reuma.2016.06.003_bib0135","article-title":"Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review","author":"Loricera","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reuma.2016.06.003_bib0140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.reuma.2016.06.003_bib0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Mart\u00ednez-Taboada","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2016.06.003_bib0150","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/annrheumdis-2013-203586","article-title":"Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial","volume":"73","author":"Seror","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2016.06.003_bib0155","doi-asserted-by":"crossref","first-page":"e115026","DOI":"10.1371\/journal.pone.0115026","article-title":"The role of biological agents in the management of large vessel vasculitis (LVV): a systematic review and meta-analysis","volume":"9","author":"Osman","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.reuma.2016.06.003_bib0160","first-page":"717","article-title":"Tocilizumab in giant cell arteritis: multicenter open label study of 22 patients","volume":"27","author":"Loricera","year":"2014","journal-title":"Semin Arthritis Rheum"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X16300638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X16300638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T07:54:43Z","timestamp":1536479683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X16300638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1699258X16300638"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2016.06.003","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2016.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}